Streetbeat News

Price Targets

ADBE

Oppenheimer analyst Brian Schwartz has reiterated an Outperform rating on Adobe (NASDAQ:ADBE) and maintained a price target of $660.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:50 am

WPRT

Oppenheimer analyst Colin Rusch maintains an Outperform rating on Westport Fuel Systems (WPRT) with a $19 price target.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:48 am

VKTX

Oppenheimer analyst Jay Olson maintains an Outperform rating on Viking Therapeutics (NASDAQ:VKTX) and raises the price target from $116 to $138.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:46 am

NFLX

Wedbush analyst Michael Pachter maintains an Outperform rating on Netflix (NASDAQ:NFLX) and raises the price target from $615 to $725.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:46 am

STRO

Oppenheimer analyst Jay Olson has maintained an Outperform rating on Sutro Biopharma (NASDAQ:STRO) and has also maintained a price target of $10 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:41 am

PLD

Barclays analyst Anthony Powell maintains an Overweight rating on Prologis (NYSE:PLD) but lowers the price target from $153 to $141.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:39 am

PRGS

Oppenheimer analyst Ittai Kidron maintains an Outperform rating on Progress Software (NASDAQ:PRGS) with a $66 price target.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:38 am

FRGE

Oppenheimer analyst Owen Lau maintains an Outperform rating on Forge Global Holdings (FRGE) with a price target of $3.5.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:36 am

CGTX

Oppenheimer analyst Jay Olson maintains an Outperform rating on Cognition Therapeutics (NASDAQ:CGTX) and keeps the price target at $9.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:34 am

CPRX

Oppenheimer analyst Leland Gershell reiterates an Outperform rating on Catalyst Pharmaceuticals (NASDAQ:CPRX) and maintains a $29 price target.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:32 am